nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC3—Vincristine—sarcoma	0.0616	0.0765	CbGbCtD
Glyburide—ABCC1—Dactinomycin—sarcoma	0.0615	0.0763	CbGbCtD
Glyburide—ABCC3—Etoposide—sarcoma	0.0565	0.0701	CbGbCtD
Glyburide—ABCC1—Mitoxantrone—sarcoma	0.055	0.0683	CbGbCtD
Glyburide—ABCB11—Vincristine—sarcoma	0.0533	0.0661	CbGbCtD
Glyburide—ABCC1—Epirubicin—sarcoma	0.0445	0.0552	CbGbCtD
Glyburide—ABCG2—Dactinomycin—sarcoma	0.0411	0.051	CbGbCtD
Glyburide—ABCC3—Doxorubicin—sarcoma	0.0385	0.0478	CbGbCtD
Glyburide—ABCC1—Vincristine—sarcoma	0.0378	0.047	CbGbCtD
Glyburide—ABCG2—Mitoxantrone—sarcoma	0.0368	0.0457	CbGbCtD
Glyburide—ABCC1—Etoposide—sarcoma	0.0347	0.043	CbGbCtD
Glyburide—ABCB11—Doxorubicin—sarcoma	0.0333	0.0413	CbGbCtD
Glyburide—ABCC2—Vincristine—sarcoma	0.028	0.0348	CbGbCtD
Glyburide—ABCC2—Etoposide—sarcoma	0.0257	0.0319	CbGbCtD
Glyburide—ABCG2—Vincristine—sarcoma	0.0253	0.0314	CbGbCtD
Glyburide—ABCC1—Doxorubicin—sarcoma	0.0237	0.0294	CbGbCtD
Glyburide—ABCG2—Etoposide—sarcoma	0.0232	0.0288	CbGbCtD
Glyburide—CYP3A4—Thiotepa—sarcoma	0.0185	0.023	CbGbCtD
Glyburide—ABCC2—Doxorubicin—sarcoma	0.0175	0.0217	CbGbCtD
Glyburide—ABCG2—Doxorubicin—sarcoma	0.0158	0.0196	CbGbCtD
Glyburide—ABCB1—Dactinomycin—sarcoma	0.0148	0.0184	CbGbCtD
Glyburide—ABCB1—Mitoxantrone—sarcoma	0.0133	0.0165	CbGbCtD
Glyburide—ABCB1—Vincristine—sarcoma	0.00913	0.0113	CbGbCtD
Glyburide—ABCB1—Etoposide—sarcoma	0.00837	0.0104	CbGbCtD
Glyburide—CYP3A4—Mitoxantrone—sarcoma	0.00795	0.00987	CbGbCtD
Glyburide—ABCB1—Doxorubicin—sarcoma	0.00571	0.00708	CbGbCtD
Glyburide—CYP3A4—Vincristine—sarcoma	0.00547	0.00679	CbGbCtD
Glyburide—KCNJ1—appendage—sarcoma	0.00523	0.0715	CbGeAlD
Glyburide—CYP3A4—Etoposide—sarcoma	0.00501	0.00622	CbGbCtD
Glyburide—ABCC9—mammary gland—sarcoma	0.00357	0.0488	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—sarcoma	0.00342	0.00424	CbGbCtD
Glyburide—KCNJ5—hematopoietic system—sarcoma	0.00287	0.0393	CbGeAlD
Glyburide—ABCA1—mammary gland—sarcoma	0.00242	0.0331	CbGeAlD
Glyburide—KCNJ5—cardiac atrium—sarcoma	0.00218	0.0298	CbGeAlD
Glyburide—Gliclazide—VEGFA—sarcoma	0.00213	1	CrCbGaD
Glyburide—KCNJ5—lymphoid tissue—sarcoma	0.00202	0.0276	CbGeAlD
Glyburide—ABCC9—smooth muscle tissue—sarcoma	0.00192	0.0262	CbGeAlD
Glyburide—CPT1A—hematopoietic system—sarcoma	0.00158	0.0216	CbGeAlD
Glyburide—KCNJ11—mammary gland—sarcoma	0.00154	0.0211	CbGeAlD
Glyburide—CPT1A—connective tissue—sarcoma	0.00153	0.0208	CbGeAlD
Glyburide—ABCA1—hematopoietic system—sarcoma	0.00148	0.0202	CbGeAlD
Glyburide—CFTR—seminal vesicle—sarcoma	0.00147	0.02	CbGeAlD
Glyburide—ABCC8—mammary gland—sarcoma	0.00142	0.0194	CbGeAlD
Glyburide—ABCA1—connective tissue—sarcoma	0.00142	0.0194	CbGeAlD
Glyburide—CFTR—hematopoietic system—sarcoma	0.00139	0.019	CbGeAlD
Glyburide—ABCA1—skin of body—sarcoma	0.00128	0.0175	CbGeAlD
Glyburide—ABCC9—testis—sarcoma	0.00119	0.0163	CbGeAlD
Glyburide—ABCC9—liver—sarcoma	0.00113	0.0154	CbGeAlD
Glyburide—SLCO2B1—mammary gland—sarcoma	0.00111	0.0152	CbGeAlD
Glyburide—CPT1A—tendon—sarcoma	0.00105	0.0143	CbGeAlD
Glyburide—ABCA1—lymphoid tissue—sarcoma	0.00104	0.0142	CbGeAlD
Glyburide—ALB—mammary gland—sarcoma	0.00102	0.0139	CbGeAlD
Glyburide—KCNJ11—hematopoietic system—sarcoma	0.000941	0.0129	CbGeAlD
Glyburide—ABCC8—seminal vesicle—sarcoma	0.000912	0.0125	CbGeAlD
Glyburide—CPT1A—testis—sarcoma	0.000868	0.0119	CbGeAlD
Glyburide—ABCC9—lymph node—sarcoma	0.000865	0.0118	CbGeAlD
Glyburide—SLC15A2—mammary gland—sarcoma	0.00085	0.0116	CbGeAlD
Glyburide—CPT1A—liver—sarcoma	0.000821	0.0112	CbGeAlD
Glyburide—ABCA1—testis—sarcoma	0.000809	0.0111	CbGeAlD
Glyburide—ABCA1—liver—sarcoma	0.000765	0.0104	CbGeAlD
Glyburide—CFTR—testis—sarcoma	0.000764	0.0104	CbGeAlD
Glyburide—ABCC8—smooth muscle tissue—sarcoma	0.000763	0.0104	CbGeAlD
Glyburide—ABCC3—hematopoietic system—sarcoma	0.000728	0.00994	CbGeAlD
Glyburide—CFTR—liver—sarcoma	0.000722	0.00987	CbGeAlD
Glyburide—SLCO2B1—hematopoietic system—sarcoma	0.000678	0.00927	CbGeAlD
Glyburide—KCNJ11—lymphoid tissue—sarcoma	0.000663	0.00905	CbGeAlD
Glyburide—CYP2C9—mammary gland—sarcoma	0.000636	0.00869	CbGeAlD
Glyburide—CPT1A—lymph node—sarcoma	0.000629	0.0086	CbGeAlD
Glyburide—ABCB11—testis—sarcoma	0.000627	0.00856	CbGeAlD
Glyburide—SLCO1A2—hematopoietic system—sarcoma	0.000624	0.00853	CbGeAlD
Glyburide—KCNJ11—tendon—sarcoma	0.000623	0.00851	CbGeAlD
Glyburide—ABCC1—myometrium—sarcoma	0.000597	0.00815	CbGeAlD
Glyburide—ABCB11—liver—sarcoma	0.000593	0.0081	CbGeAlD
Glyburide—ABCA1—lymph node—sarcoma	0.000586	0.00801	CbGeAlD
Glyburide—SLC22A7—testis—sarcoma	0.000565	0.00772	CbGeAlD
Glyburide—SLC15A2—seminal vesicle—sarcoma	0.000545	0.00745	CbGeAlD
Glyburide—ABCC1—seminal vesicle—sarcoma	0.000539	0.00736	CbGeAlD
Glyburide—SLC22A7—liver—sarcoma	0.000534	0.0073	CbGeAlD
Glyburide—SLCO2B1—uterus—sarcoma	0.000512	0.007	CbGeAlD
Glyburide—CYP2C19—hematopoietic system—sarcoma	0.0005	0.00683	CbGeAlD
Glyburide—ABCG2—myometrium—sarcoma	0.000494	0.00675	CbGeAlD
Glyburide—ABCC8—testis—sarcoma	0.000475	0.00649	CbGeAlD
Glyburide—SLCO2B1—tendon—sarcoma	0.000449	0.00613	CbGeAlD
Glyburide—ABCG2—seminal vesicle—sarcoma	0.000446	0.0061	CbGeAlD
Glyburide—Erythema—Dactinomycin—sarcoma	0.000438	0.00368	CcSEcCtD
Glyburide—Hepatitis—Mitoxantrone—sarcoma	0.000438	0.00368	CcSEcCtD
Glyburide—Pancytopenia—Etoposide—sarcoma	0.000432	0.00363	CcSEcCtD
Glyburide—SLC15A1—liver—sarcoma	0.000429	0.00587	CbGeAlD
Glyburide—Jaundice cholestatic—Doxorubicin—sarcoma	0.000428	0.0036	CcSEcCtD
Glyburide—Vision blurred—Thiotepa—sarcoma	0.000416	0.0035	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.000414	0.00348	CcSEcCtD
Glyburide—Anaemia—Thiotepa—sarcoma	0.000408	0.00343	CcSEcCtD
Glyburide—Anaemia—Dactinomycin—sarcoma	0.000405	0.0034	CcSEcCtD
Glyburide—ABCC3—testis—sarcoma	0.000399	0.00545	CbGeAlD
Glyburide—Alopecia—Vincristine—sarcoma	0.000397	0.00334	CcSEcCtD
Glyburide—Jaundice—Etoposide—sarcoma	0.000395	0.00332	CcSEcCtD
Glyburide—Leukopenia—Thiotepa—sarcoma	0.000395	0.00332	CcSEcCtD
Glyburide—Leukopenia—Dactinomycin—sarcoma	0.000392	0.0033	CcSEcCtD
Glyburide—ABCC1—cardiac atrium—sarcoma	0.000389	0.00531	CbGeAlD
Glyburide—CYP2C9—hematopoietic system—sarcoma	0.000387	0.00529	CbGeAlD
Glyburide—ABCC1—uterus—sarcoma	0.000387	0.00529	CbGeAlD
Glyburide—Alopecia—Mitoxantrone—sarcoma	0.000387	0.00325	CcSEcCtD
Glyburide—ABCC2—tendon—sarcoma	0.000385	0.00526	CbGeAlD
Glyburide—Convulsion—Thiotepa—sarcoma	0.000382	0.00322	CcSEcCtD
Glyburide—Aplastic anaemia—Epirubicin—sarcoma	0.000382	0.00321	CcSEcCtD
Glyburide—Erythema—Mitoxantrone—sarcoma	0.000381	0.0032	CcSEcCtD
Glyburide—Agranulocytosis—Etoposide—sarcoma	0.000378	0.00318	CcSEcCtD
Glyburide—ABCC3—liver—sarcoma	0.000377	0.00515	CbGeAlD
Glyburide—Myalgia—Thiotepa—sarcoma	0.000376	0.00316	CcSEcCtD
Glyburide—Arthralgia—Thiotepa—sarcoma	0.000376	0.00316	CcSEcCtD
Glyburide—KCNJ11—lymph node—sarcoma	0.000374	0.00511	CbGeAlD
Glyburide—Myalgia—Dactinomycin—sarcoma	0.000373	0.00314	CcSEcCtD
Glyburide—SLCO2B1—testis—sarcoma	0.000372	0.00508	CbGeAlD
Glyburide—Confusional state—Thiotepa—sarcoma	0.000363	0.00305	CcSEcCtD
Glyburide—Anaemia—Vincristine—sarcoma	0.000362	0.00304	CcSEcCtD
Glyburide—Vision blurred—Mitoxantrone—sarcoma	0.000359	0.00302	CcSEcCtD
Glyburide—Oedema—Dactinomycin—sarcoma	0.000357	0.00301	CcSEcCtD
Glyburide—Nervous system disorder—Thiotepa—sarcoma	0.000353	0.00297	CcSEcCtD
Glyburide—Aplastic anaemia—Doxorubicin—sarcoma	0.000353	0.00297	CcSEcCtD
Glyburide—Thrombocytopenia—Thiotepa—sarcoma	0.000353	0.00297	CcSEcCtD
Glyburide—Anaemia—Mitoxantrone—sarcoma	0.000352	0.00296	CcSEcCtD
Glyburide—SLCO2B1—liver—sarcoma	0.000351	0.0048	CbGeAlD
Glyburide—Leukopenia—Vincristine—sarcoma	0.00035	0.00295	CcSEcCtD
Glyburide—Thrombocytopenia—Dactinomycin—sarcoma	0.00035	0.00294	CcSEcCtD
Glyburide—Anorexia—Thiotepa—sarcoma	0.000343	0.00289	CcSEcCtD
Glyburide—SLCO1A2—testis—sarcoma	0.000342	0.00467	CbGeAlD
Glyburide—Leukopenia—Mitoxantrone—sarcoma	0.000341	0.00287	CcSEcCtD
Glyburide—Anorexia—Dactinomycin—sarcoma	0.000341	0.00287	CcSEcCtD
Glyburide—Eye disorder—Etoposide—sarcoma	0.00034	0.00286	CcSEcCtD
Glyburide—ALB—testis—sarcoma	0.00034	0.00465	CbGeAlD
Glyburide—ABCC1—tendon—sarcoma	0.000339	0.00463	CbGeAlD
Glyburide—Convulsion—Vincristine—sarcoma	0.000339	0.00285	CcSEcCtD
Glyburide—Hepatic function abnormal—Epirubicin—sarcoma	0.000338	0.00284	CcSEcCtD
Glyburide—Myalgia—Vincristine—sarcoma	0.000333	0.0028	CcSEcCtD
Glyburide—Convulsion—Mitoxantrone—sarcoma	0.00033	0.00278	CcSEcCtD
Glyburide—Vascular purpura—Epirubicin—sarcoma	0.00033	0.00277	CcSEcCtD
Glyburide—Hepatic failure—Epirubicin—sarcoma	0.000328	0.00276	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000328	0.00276	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000326	0.00274	CcSEcCtD
Glyburide—Arthralgia—Mitoxantrone—sarcoma	0.000324	0.00273	CcSEcCtD
Glyburide—Myalgia—Mitoxantrone—sarcoma	0.000324	0.00273	CcSEcCtD
Glyburide—SLCO1A2—liver—sarcoma	0.000323	0.00442	CbGeAlD
Glyburide—Paraesthesia—Thiotepa—sarcoma	0.000323	0.00272	CcSEcCtD
Glyburide—Alopecia—Etoposide—sarcoma	0.000322	0.00271	CcSEcCtD
Glyburide—ALB—liver—sarcoma	0.000322	0.00439	CbGeAlD
Glyburide—ABCG2—uterus—sarcoma	0.00032	0.00438	CbGeAlD
Glyburide—Renal failure acute—Epirubicin—sarcoma	0.00032	0.00269	CcSEcCtD
Glyburide—Oedema—Vincristine—sarcoma	0.000319	0.00269	CcSEcCtD
Glyburide—ABCC2—testis—sarcoma	0.000319	0.00435	CbGeAlD
Glyburide—Dyspepsia—Thiotepa—sarcoma	0.000317	0.00267	CcSEcCtD
Glyburide—Confusional state—Mitoxantrone—sarcoma	0.000314	0.00264	CcSEcCtD
Glyburide—Nervous system disorder—Vincristine—sarcoma	0.000313	0.00263	CcSEcCtD
Glyburide—Decreased appetite—Thiotepa—sarcoma	0.000313	0.00263	CcSEcCtD
Glyburide—Thrombocytopenia—Vincristine—sarcoma	0.000313	0.00263	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—sarcoma	0.000312	0.00263	CcSEcCtD
Glyburide—Oedema—Mitoxantrone—sarcoma	0.000311	0.00262	CcSEcCtD
Glyburide—Gastrointestinal disorder—Thiotepa—sarcoma	0.000311	0.00261	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—sarcoma	0.000311	0.00261	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—sarcoma	0.00031	0.00261	CcSEcCtD
Glyburide—Hyperhidrosis—Vincristine—sarcoma	0.000309	0.0026	CcSEcCtD
Glyburide—Dermatitis bullous—Epirubicin—sarcoma	0.000309	0.0026	CcSEcCtD
Glyburide—Purpura—Epirubicin—sarcoma	0.000306	0.00257	CcSEcCtD
Glyburide—Shock—Mitoxantrone—sarcoma	0.000306	0.00257	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—sarcoma	0.000305	0.00257	CcSEcCtD
Glyburide—Thrombocytopenia—Mitoxantrone—sarcoma	0.000304	0.00256	CcSEcCtD
Glyburide—Anorexia—Vincristine—sarcoma	0.000304	0.00256	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—sarcoma	0.000304	0.00255	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—sarcoma	0.000302	0.00254	CcSEcCtD
Glyburide—ABCC2—liver—sarcoma	0.000301	0.00412	CbGeAlD
Glyburide—Hyperhidrosis—Mitoxantrone—sarcoma	0.000301	0.00253	CcSEcCtD
Glyburide—Hypotension—Vincristine—sarcoma	0.000298	0.00251	CcSEcCtD
Glyburide—Feeling abnormal—Thiotepa—sarcoma	0.000297	0.0025	CcSEcCtD
Glyburide—Anorexia—Mitoxantrone—sarcoma	0.000296	0.00249	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—sarcoma	0.000296	0.00249	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—sarcoma	0.000296	0.00249	CcSEcCtD
Glyburide—CYP3A4—hematopoietic system—sarcoma	0.000295	0.00404	CbGeAlD
Glyburide—Diplopia—Epirubicin—sarcoma	0.000295	0.00248	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—sarcoma	0.000295	0.00248	CcSEcCtD
Glyburide—Gastrointestinal pain—Thiotepa—sarcoma	0.000294	0.00248	CcSEcCtD
Glyburide—Anaemia—Etoposide—sarcoma	0.000293	0.00246	CcSEcCtD
Glyburide—Gastrointestinal pain—Dactinomycin—sarcoma	0.000292	0.00246	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Vincristine—sarcoma	0.000291	0.00245	CcSEcCtD
Glyburide—Hypotension—Mitoxantrone—sarcoma	0.000291	0.00244	CcSEcCtD
Glyburide—ABCC3—lymph node—sarcoma	0.000289	0.00395	CbGeAlD
Glyburide—Renal impairment—Doxorubicin—sarcoma	0.000287	0.00241	CcSEcCtD
Glyburide—Paraesthesia—Vincristine—sarcoma	0.000287	0.00241	CcSEcCtD
Glyburide—Urticaria—Thiotepa—sarcoma	0.000286	0.00241	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—sarcoma	0.000286	0.0024	CcSEcCtD
Glyburide—Abdominal pain—Thiotepa—sarcoma	0.000285	0.00239	CcSEcCtD
Glyburide—SLC15A2—testis—sarcoma	0.000284	0.00388	CbGeAlD
Glyburide—Leukopenia—Etoposide—sarcoma	0.000284	0.00239	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000283	0.00238	CcSEcCtD
Glyburide—Purpura—Doxorubicin—sarcoma	0.000283	0.00238	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—sarcoma	0.000283	0.00238	CcSEcCtD
Glyburide—ABCC1—testis—sarcoma	0.000281	0.00384	CbGeAlD
Glyburide—Hypoglycaemia—Doxorubicin—sarcoma	0.00028	0.00235	CcSEcCtD
Glyburide—Paraesthesia—Mitoxantrone—sarcoma	0.000279	0.00235	CcSEcCtD
Glyburide—Decreased appetite—Vincristine—sarcoma	0.000278	0.00233	CcSEcCtD
Glyburide—Dyspnoea—Mitoxantrone—sarcoma	0.000277	0.00233	CcSEcCtD
Glyburide—Gastrointestinal disorder—Vincristine—sarcoma	0.000276	0.00232	CcSEcCtD
Glyburide—Convulsion—Etoposide—sarcoma	0.000275	0.00231	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—sarcoma	0.000274	0.0023	CcSEcCtD
Glyburide—Dyspepsia—Mitoxantrone—sarcoma	0.000274	0.0023	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—sarcoma	0.000273	0.0023	CcSEcCtD
Glyburide—ABCG2—bone marrow—sarcoma	0.000272	0.00371	CbGeAlD
Glyburide—Decreased appetite—Mitoxantrone—sarcoma	0.00027	0.00227	CcSEcCtD
Glyburide—SLCO2B1—lymph node—sarcoma	0.000269	0.00368	CbGeAlD
Glyburide—ABCC1—liver—sarcoma	0.000265	0.00363	CbGeAlD
Glyburide—Hypersensitivity—Thiotepa—sarcoma	0.000265	0.00223	CcSEcCtD
Glyburide—Hypersensitivity—Dactinomycin—sarcoma	0.000263	0.00221	CcSEcCtD
Glyburide—Gastrointestinal pain—Vincristine—sarcoma	0.000261	0.0022	CcSEcCtD
Glyburide—Confusional state—Etoposide—sarcoma	0.000261	0.00219	CcSEcCtD
Glyburide—CYP2C19—liver—sarcoma	0.000259	0.00354	CbGeAlD
Glyburide—Asthenia—Thiotepa—sarcoma	0.000258	0.00217	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—sarcoma	0.000257	0.00216	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—sarcoma	0.000256	0.00216	CcSEcCtD
Glyburide—Feeling abnormal—Mitoxantrone—sarcoma	0.000256	0.00216	CcSEcCtD
Glyburide—Pruritus—Thiotepa—sarcoma	0.000255	0.00214	CcSEcCtD
Glyburide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000254	0.00214	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—sarcoma	0.000253	0.00213	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—sarcoma	0.000252	0.00212	CcSEcCtD
Glyburide—Abdominal pain—Vincristine—sarcoma	0.000252	0.00212	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—sarcoma	0.00025	0.0021	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—sarcoma	0.00025	0.0021	CcSEcCtD
Glyburide—Urticaria—Mitoxantrone—sarcoma	0.000247	0.00208	CcSEcCtD
Glyburide—Anorexia—Etoposide—sarcoma	0.000247	0.00207	CcSEcCtD
Glyburide—ALB—lymph node—sarcoma	0.000247	0.00337	CbGeAlD
Glyburide—Diarrhoea—Thiotepa—sarcoma	0.000246	0.00207	CcSEcCtD
Glyburide—Abdominal pain—Mitoxantrone—sarcoma	0.000246	0.00207	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—sarcoma	0.000245	0.00206	CcSEcCtD
Glyburide—ABCB1—myometrium—sarcoma	0.000244	0.00333	CbGeAlD
Glyburide—Pancytopenia—Epirubicin—sarcoma	0.000242	0.00204	CcSEcCtD
Glyburide—Hypotension—Etoposide—sarcoma	0.000242	0.00203	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—sarcoma	0.000238	0.002	CcSEcCtD
Glyburide—Hypersensitivity—Vincristine—sarcoma	0.000235	0.00198	CcSEcCtD
Glyburide—ABCB1—embryo—sarcoma	0.000234	0.0032	CbGeAlD
Glyburide—Eosinophilia—Doxorubicin—sarcoma	0.000234	0.00196	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—sarcoma	0.000233	0.00196	CcSEcCtD
Glyburide—ABCG2—testis—sarcoma	0.000232	0.00318	CbGeAlD
Glyburide—Paraesthesia—Etoposide—sarcoma	0.000232	0.00195	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—sarcoma	0.000231	0.00195	CcSEcCtD
Glyburide—ABCC2—lymph node—sarcoma	0.000231	0.00316	CbGeAlD
Glyburide—Dyspnoea—Etoposide—sarcoma	0.000231	0.00194	CcSEcCtD
Glyburide—Hypersensitivity—Mitoxantrone—sarcoma	0.000229	0.00193	CcSEcCtD
Glyburide—Asthenia—Vincristine—sarcoma	0.000229	0.00193	CcSEcCtD
Glyburide—Vomiting—Thiotepa—sarcoma	0.000229	0.00193	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—sarcoma	0.000227	0.00191	CcSEcCtD
Glyburide—Rash—Thiotepa—sarcoma	0.000227	0.00191	CcSEcCtD
Glyburide—Dermatitis—Thiotepa—sarcoma	0.000227	0.00191	CcSEcCtD
Glyburide—Headache—Thiotepa—sarcoma	0.000226	0.0019	CcSEcCtD
Glyburide—Rash—Dactinomycin—sarcoma	0.000225	0.0019	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—sarcoma	0.000225	0.00189	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—sarcoma	0.000224	0.00188	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—sarcoma	0.000223	0.00188	CcSEcCtD
Glyburide—Asthenia—Mitoxantrone—sarcoma	0.000223	0.00188	CcSEcCtD
Glyburide—Jaundice—Epirubicin—sarcoma	0.000222	0.00186	CcSEcCtD
Glyburide—ABCB1—seminal vesicle—sarcoma	0.00022	0.00301	CbGeAlD
Glyburide—ABCG2—liver—sarcoma	0.00022	0.003	CbGeAlD
Glyburide—Diarrhoea—Vincristine—sarcoma	0.000218	0.00184	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—sarcoma	0.000215	0.00181	CcSEcCtD
Glyburide—Nausea—Thiotepa—sarcoma	0.000214	0.0018	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—sarcoma	0.000213	0.00179	CcSEcCtD
Glyburide—Diarrhoea—Mitoxantrone—sarcoma	0.000213	0.00179	CcSEcCtD
Glyburide—Nausea—Dactinomycin—sarcoma	0.000212	0.00179	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—sarcoma	0.000212	0.00178	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—sarcoma	0.000212	0.00178	CcSEcCtD
Glyburide—ABCB1—hematopoietic system—sarcoma	0.000209	0.00286	CbGeAlD
Glyburide—SLC15A2—lymph node—sarcoma	0.000206	0.00281	CbGeAlD
Glyburide—Urticaria—Etoposide—sarcoma	0.000205	0.00173	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—sarcoma	0.000205	0.00172	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—sarcoma	0.000204	0.00172	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—sarcoma	0.000204	0.00172	CcSEcCtD
Glyburide—ABCC1—lymph node—sarcoma	0.000204	0.00278	CbGeAlD
Glyburide—Vomiting—Vincristine—sarcoma	0.000203	0.00171	CcSEcCtD
Glyburide—Rash—Vincristine—sarcoma	0.000201	0.00169	CcSEcCtD
Glyburide—Dermatitis—Vincristine—sarcoma	0.000201	0.00169	CcSEcCtD
Glyburide—CYP2C9—liver—sarcoma	0.000201	0.00274	CbGeAlD
Glyburide—Headache—Vincristine—sarcoma	0.0002	0.00168	CcSEcCtD
Glyburide—Vomiting—Mitoxantrone—sarcoma	0.000198	0.00166	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—sarcoma	0.000197	0.00165	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—sarcoma	0.000196	0.00165	CcSEcCtD
Glyburide—Rash—Mitoxantrone—sarcoma	0.000196	0.00165	CcSEcCtD
Glyburide—Dermatitis—Mitoxantrone—sarcoma	0.000196	0.00165	CcSEcCtD
Glyburide—Headache—Mitoxantrone—sarcoma	0.000195	0.00164	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—sarcoma	0.000191	0.0016	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—sarcoma	0.000191	0.0016	CcSEcCtD
Glyburide—Nausea—Vincristine—sarcoma	0.00019	0.0016	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—sarcoma	0.000189	0.00159	CcSEcCtD
Glyburide—Asthenia—Etoposide—sarcoma	0.000186	0.00156	CcSEcCtD
Glyburide—Nausea—Mitoxantrone—sarcoma	0.000185	0.00155	CcSEcCtD
Glyburide—Pruritus—Etoposide—sarcoma	0.000183	0.00154	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—sarcoma	0.000182	0.00153	CcSEcCtD
Glyburide—Alopecia—Epirubicin—sarcoma	0.00018	0.00152	CcSEcCtD
Glyburide—Erythema—Epirubicin—sarcoma	0.000178	0.00149	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—sarcoma	0.000178	0.00149	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—sarcoma	0.000177	0.00149	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—sarcoma	0.000176	0.00148	CcSEcCtD
Glyburide—ABCG2—lymph node—sarcoma	0.000168	0.0023	CbGeAlD
Glyburide—Vision blurred—Epirubicin—sarcoma	0.000167	0.00141	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—sarcoma	0.000167	0.0014	CcSEcCtD
Glyburide—Vomiting—Etoposide—sarcoma	0.000164	0.00138	CcSEcCtD
Glyburide—Erythema—Doxorubicin—sarcoma	0.000164	0.00138	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—sarcoma	0.000164	0.00138	CcSEcCtD
Glyburide—Anaemia—Epirubicin—sarcoma	0.000164	0.00138	CcSEcCtD
Glyburide—Rash—Etoposide—sarcoma	0.000163	0.00137	CcSEcCtD
Glyburide—Dermatitis—Etoposide—sarcoma	0.000163	0.00137	CcSEcCtD
Glyburide—Headache—Etoposide—sarcoma	0.000162	0.00136	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—sarcoma	0.000159	0.00134	CcSEcCtD
Glyburide—ABCB1—uterus—sarcoma	0.000158	0.00216	CbGeAlD
Glyburide—Vision blurred—Doxorubicin—sarcoma	0.000155	0.0013	CcSEcCtD
Glyburide—Convulsion—Epirubicin—sarcoma	0.000154	0.00129	CcSEcCtD
Glyburide—Nausea—Etoposide—sarcoma	0.000154	0.00129	CcSEcCtD
Glyburide—CYP3A4—liver—sarcoma	0.000153	0.00209	CbGeAlD
Glyburide—Anaemia—Doxorubicin—sarcoma	0.000152	0.00128	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—sarcoma	0.000151	0.00127	CcSEcCtD
Glyburide—Myalgia—Epirubicin—sarcoma	0.000151	0.00127	CcSEcCtD
Glyburide—ABCB1—lymphoid tissue—sarcoma	0.000147	0.00201	CbGeAlD
Glyburide—Leukopenia—Doxorubicin—sarcoma	0.000147	0.00124	CcSEcCtD
Glyburide—Confusional state—Epirubicin—sarcoma	0.000146	0.00123	CcSEcCtD
Glyburide—Oedema—Epirubicin—sarcoma	0.000145	0.00122	CcSEcCtD
Glyburide—Shock—Epirubicin—sarcoma	0.000143	0.0012	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—sarcoma	0.000142	0.0012	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—sarcoma	0.000142	0.0012	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—sarcoma	0.000142	0.00119	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—sarcoma	0.00014	0.00118	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—sarcoma	0.00014	0.00118	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—sarcoma	0.00014	0.00118	CcSEcCtD
Glyburide—Anorexia—Epirubicin—sarcoma	0.000138	0.00116	CcSEcCtD
Glyburide—Hypotension—Epirubicin—sarcoma	0.000135	0.00114	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—sarcoma	0.000135	0.00114	CcSEcCtD
Glyburide—Oedema—Doxorubicin—sarcoma	0.000134	0.00113	CcSEcCtD
Glyburide—ABCB1—bone marrow—sarcoma	0.000134	0.00183	CbGeAlD
Glyburide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000132	0.00111	CcSEcCtD
Glyburide—Shock—Doxorubicin—sarcoma	0.000132	0.00111	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—sarcoma	0.000132	0.00111	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—sarcoma	0.000131	0.0011	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—sarcoma	0.00013	0.00109	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—sarcoma	0.00013	0.00109	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—sarcoma	0.000129	0.00109	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—sarcoma	0.000128	0.00108	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—sarcoma	0.000128	0.00107	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—sarcoma	0.000126	0.00106	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—sarcoma	0.000125	0.00105	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—sarcoma	0.000125	0.00105	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000122	0.00103	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—sarcoma	0.00012	0.00101	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—sarcoma	0.00012	0.00101	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—sarcoma	0.000119	0.001	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—sarcoma	0.000119	0.000997	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—sarcoma	0.000118	0.000993	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—sarcoma	0.000117	0.000981	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000116	0.000974	CcSEcCtD
Glyburide—Urticaria—Epirubicin—sarcoma	0.000115	0.000969	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—sarcoma	0.000115	0.000964	CcSEcCtD
Glyburide—ABCB1—testis—sarcoma	0.000115	0.00157	CbGeAlD
Glyburide—Feeling abnormal—Doxorubicin—sarcoma	0.000111	0.00093	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—sarcoma	0.00011	0.000923	CcSEcCtD
Glyburide—ABCB1—liver—sarcoma	0.000108	0.00148	CbGeAlD
Glyburide—Hypersensitivity—Epirubicin—sarcoma	0.000107	0.000898	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—sarcoma	0.000107	0.000896	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—sarcoma	0.000106	0.000892	CcSEcCtD
Glyburide—Asthenia—Epirubicin—sarcoma	0.000104	0.000875	CcSEcCtD
Glyburide—Pruritus—Epirubicin—sarcoma	0.000103	0.000863	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—sarcoma	9.92e-05	0.000834	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—sarcoma	9.88e-05	0.000831	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—sarcoma	9.63e-05	0.00081	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—sarcoma	9.49e-05	0.000798	CcSEcCtD
Glyburide—Vomiting—Epirubicin—sarcoma	9.22e-05	0.000775	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—sarcoma	9.18e-05	0.000772	CcSEcCtD
Glyburide—Rash—Epirubicin—sarcoma	9.14e-05	0.000769	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—sarcoma	9.13e-05	0.000768	CcSEcCtD
Glyburide—Headache—Epirubicin—sarcoma	9.08e-05	0.000764	CcSEcCtD
Glyburide—Nausea—Epirubicin—sarcoma	8.61e-05	0.000724	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—sarcoma	8.53e-05	0.000717	CcSEcCtD
Glyburide—Rash—Doxorubicin—sarcoma	8.46e-05	0.000711	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—sarcoma	8.45e-05	0.000711	CcSEcCtD
Glyburide—Headache—Doxorubicin—sarcoma	8.4e-05	0.000707	CcSEcCtD
Glyburide—ABCB1—lymph node—sarcoma	8.31e-05	0.00114	CbGeAlD
Glyburide—Nausea—Doxorubicin—sarcoma	7.97e-05	0.00067	CcSEcCtD
